EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic Biomimetic Liposomes Harness Efferocytosis Machinery for Highly Efficient Macrophages‐Targeted Drug Delivery to Alleviate Inflammation

Run Han, Zhengyu Ren, Qi Wang, Haidong Zha, Erjin Wang, Mingyue Wu, Ying Zheng, Jia-Hong Lu iD

Advanced Science · 2024-08 · 11 (29)

DOI: 10.1002/advs.202308325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.05.2024. Verfasst von Run Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, 999078, China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Inflammation, Liposomes, Macrophages. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macau Science and Technology Development Fund, Shenzhen Fundamental Research Program, University of Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages play pivotal roles in the regulation of inflammatory responses and tissue repair, making them a prime target for inflammation alleviation. However, the accurate and efficient macrophages targeting is still a challenging task. Motivated by the efficient and specific removal of apoptotic cells by macrophages efferocytosis, a novel biomimetic liposomal system called Effero‐RLP (Efferocytosis‐mediated Red blood cell hybrid Liposomes) is developed which incorporates the membrane of apoptotic red blood cells (RBCs) with liposomes for the purpose of highly efficient macrophages targeting. Rosiglitazone (ROSI), a PPARγ agonist known to attenuate macrophage inflammatory responses, is encapsulated into Effero‐RLP as model drug to regulate macrophage functions in DSS‐induced colitis mouse model. Intriguingly, the Effero‐RLP exhibits selective and efficient uptake by macrophages, which is significantly inhibited by the efferocytosis blocker Annexin V. In animal models, the Effero‐RLP demonstrates rapid recognition by macrophages, leading to enhanced accumulation at inflammatory sites. Furthermore, ROSI‐loaded Effero‐RLP effectively alleviates inflammation and protects colon tissue from injury in the colitis mouse model, which is abolished by deletion of macrophages from mice model. In conclusion, the study highlights the potential of macrophage targeting using efferocytosis biomimetic liposomes. The development of Effero‐RLP presents novel and promising strategies for alleviating inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsInflammationLiposomesMacrophagesAnimalsMiceBiomimeticsColitisDisease Models, AnimalEfferocytosisMice, Inbred C57BLRosiglitazone

Stichwörter der Autor:innen

biomimeticefferocytosisinflammatory bowel disease (IBD)liposomemacrophage targeting

Substanzen

LiposomesRosiglitazone

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, 999078, China.
  • State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, 210023, China.
  • Faculty of Health Sciences, University of Macau, Macau, 999078, China.
  • Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, University of Macau, Macau, 999078, China.

ORCID-Profile: Jia-Hong Lu

Förderung

  • Macau Science and Technology Development Fund
  • Shenzhen Fundamental Research Program
  • University of Macau
  • Guangdong Provincial Science and Technology Innovation Strategy Special Fund
  • Macao Young Scholars Program
  • Universidade de Macau

Zitieren

APA

Han, R., Ren, Z., Wang, Q., Zha, H., Wang, E., Wu, M., Zheng, Y., & Lu, J. H. (2024). Synthetic Biomimetic Liposomes Harness Efferocytosis Machinery for Highly Efficient Macrophages‐Targeted Drug Delivery to Alleviate Inflammation. Advanced Science, 11(29). https://doi.org/10.1002/advs.202308325

Vancouver

Han R, Ren Z, Wang Q, Zha H, Wang E, Wu M, et al. Synthetic Biomimetic Liposomes Harness Efferocytosis Machinery for Highly Efficient Macrophages‐Targeted Drug Delivery to Alleviate Inflammation. Advanced Science. 2024;11(29). doi:10.1002/advs.202308325

BibTeX
@article{Han2024,
  author = {Han, Run and Ren, Zhengyu and Wang, Qi and Zha, Haidong and Wang, Erjin and Wu, Mingyue and Zheng, Ying and Lu, Jia-Hong},
  title = {Synthetic Biomimetic Liposomes Harness Efferocytosis Machinery for Highly Efficient Macrophages‐Targeted Drug Delivery to Alleviate Inflammation},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {29},
  doi = {10.1002/advs.202308325}
}
Kostenlos starten →